191 related articles for article (PubMed ID: 29922943)
1. Simultaneous PET/MRI in assessing the response to chemo/radiotherapy in head and neck carcinoma: initial experience.
Romeo V; Iorio B; Mesolella M; Ugga L; Verde F; Nicolai E; Covello M
Med Oncol; 2018 Jun; 35(7):112. PubMed ID: 29922943
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.
Covello M; Cavaliere C; Aiello M; Cianelli MS; Mesolella M; Iorio B; Rossi A; Nicolai E
Eur J Radiol; 2015 Jul; 84(7):1269-76. PubMed ID: 25958189
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-Weighted MRI in the Assessment of Early Treatment Response in Patients with Squamous-Cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings.
Martins EB; Chojniak R; Kowalski LP; Nicolau UR; Lima EN; Bitencourt AG
PLoS One; 2015; 10(11):e0140009. PubMed ID: 26562784
[TBL] [Abstract][Full Text] [Related]
4. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
5. Associations Between Histogram Analysis DCE MRI Parameters and Complex
Surov A; Leifels L; Meyer HJ; Winter K; Sabri O; Purz S
Anticancer Res; 2018 Mar; 38(3):1637-1642. PubMed ID: 29491096
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
[TBL] [Abstract][Full Text] [Related]
7. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer.
Cavaliere C; Romeo V; Aiello M; Mesolella M; Iorio B; Barbuto L; Cantone E; Nicolai E; Covello M
Eur J Radiol; 2017 Mar; 88():47-55. PubMed ID: 28189208
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma.
Rasmussen JH; Nørgaard M; Hansen AE; Vogelius IR; Aznar MC; Johannesen HH; Costa J; Engberg AM; Kjær A; Specht L; Fischer BM
J Nucl Med; 2017 Jan; 58(1):69-74. PubMed ID: 27609790
[TBL] [Abstract][Full Text] [Related]
10. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
[TBL] [Abstract][Full Text] [Related]
12. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of tumor hypoxia assessed by 18F-FAZA PET/CT in head and neck and lung cancer patients during chemoradiation: possible implications for radiotherapy treatment planning strategies.
Bollineni VR; Koole MJ; Pruim J; Brouwer CL; Wiegman EM; Groen HJ; Vlasman R; Halmos GB; Oosting SF; Langendijk JA; Widder J; Steenbakkers RJ
Radiother Oncol; 2014 Nov; 113(2):198-203. PubMed ID: 25434768
[TBL] [Abstract][Full Text] [Related]
14. Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET/MRI: A single-center study.
Wongsa P; Nantasuk M; Singhnoi S; Pawano P; Jantarato A; Siripongsatian D; Lerdsirisuk P; Phonlakrai M
J Appl Clin Med Phys; 2023 May; 24(5):e13928. PubMed ID: 36763489
[TBL] [Abstract][Full Text] [Related]
15. PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study.
Rogasch J; Beck M; Stromberger C; Hofheinz F; Ghadjar P; Wust P; Budach V; Amthauer H; Tinhofer I; Furth C; Walter-Rittel TC; Zschaeck S
F1000Res; 2020; 9():1350. PubMed ID: 33796277
[No Abstract] [Full Text] [Related]
16. Predictive value of SUV-based parameters derived from pre-treatment (18)F-FLT PET/CT for short-term outcome with head and neck cancers.
Hoshikawa H; Yamamoto Y; Mori T; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
Ann Nucl Med; 2014 Dec; 28(10):1020-6. PubMed ID: 25179522
[TBL] [Abstract][Full Text] [Related]
17. The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer: A Cross-Sectional Analysis in Single Institute.
Han M; Kim SY; Lee SJ; Choi JW
Medicine (Baltimore); 2015 Nov; 94(47):e2141. PubMed ID: 26632740
[TBL] [Abstract][Full Text] [Related]
18. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
Wong KH; Panek R; Dunlop A; Mcquaid D; Riddell A; Welsh LC; Murray I; Koh DM; Leach MO; Bhide SA; Nutting CM; Oyen WJ; Harrington KJ; Newbold KL
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):759-767. PubMed ID: 29164301
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
20. Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Castaldi P; Rufini V; Bussu F; Miccichè F; Dinapoli N; Autorino R; Lago M; De Corso E; Almadori G; Galli J; Paludetti G; Giordano A; Valentini V
Radiother Oncol; 2012 Apr; 103(1):63-8. PubMed ID: 22459579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
